IGF-1 LR3 – Long-Acting IGF-1 Analogue for Research Applications
IGF-1 LR3 (Insulin-like Growth Factor 1 Long Arg3) is a synthetic
research peptide derived from the naturally occurring IGF-1 protein.
This extended variant (LR3) is designed for laboratory research focused on
cell growth, muscle tissue development, and metabolic signal transduction
under in-vitro conditions.
IGF-1 LR3 contains an extended N-terminal peptide chain with an arginine substitution
at position 3, resulting in an increased half-life and enhanced receptor-binding
capacity in research models. The product is verified using
High-Performance Liquid Chromatography (HPLC) to ensure a purity of
≥ 97.8%.
Key specifications
| Specification | Value / description |
|---|---|
| Name | IGF-1 LR3 (Long Arg3) |
| Molecular formula | C332H515N97O98S7 |
| Molecular weight | ≈ 9,117 Da |
| Form | Lyophilized powder |
| Purity | ≥ 97.8% (HPLC tested) |
| Storage conditions | Store refrigerated, protected from light and moisture |
Research relevance
IGF-1 LR3 is widely used in research settings to investigate
cell proliferation, tissue regeneration, and insulin-like signaling pathways.
It is of particular interest for studies focused on
IGF receptor activation and
protein synthesis in muscle cell models,
and is commonly applied in endocrinological and anabolic research under in-vitro conditions.
- Used in studies related to cell growth and tissue regeneration.
- Relevant for research on IGF receptor signaling pathways.
- Applied in investigations of protein synthesis in muscle cell models.
- Lyophilized form supports stable storage and controlled laboratory handling.
